Literature DB >> 16616450

Randomized controlled trial of a social support ('buddy') intervention for smoking cessation.

Sylvia May1, Robert West, Peter Hajek, Andy McEwen, Hayden McRobbie.   

Abstract

OBJECTIVE: To assess the effectiveness of including a social support intervention ('buddy system') in a group treatment programme to aid smoking cessation.
METHODS: Five hundred and sixty-three smokers attended groups at a smokers' clinic. These groups were randomized either to be (a) groups in which smokers were paired with another person to provide mutual support (buddy condition: n=237 in 14 groups) or (b) to receive the same treatment without the buddy component (control: n=326 in 20 groups). Participants were seen weekly for the first 4 weeks after stopping then followed up again after 26 weeks.
RESULTS: Smokers in the buddy condition were no more likely than smokers in the control condition to stay abstinent at 1, 4 or 26 weeks. The effect was in the right direction at week one post-quit but after controlling for potential confounders the difference was not significant (odds ratio=1.45 (95% CI; 0.92-2.29), p=0.06).
CONCLUSIONS: We were unable to show that a buddy system improved abstinence rates of group treatment programmes. This might be due to the high level of social support already achieved through the groups. PRACTICE IMPLICATIONS: The buddy system is a simple and very low cost addition to a group treatment programme; but the results from this study suggest that the kind of buddy system tested may not add substantially to the success rates. However there may be merits in a more intensive or protracted form of buddying.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616450     DOI: 10.1016/j.pec.2006.02.008

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  23 in total

1.  'Closet' quit attempts: prevalence, correlates and association with outcome.

Authors:  Matthew J Carpenter; Katherine Regan Sterba; Amy S Boatright; Robert West
Journal:  Addiction       Date:  2011-08-23       Impact factor: 6.526

2.  Drinking buddies and their prospective influence on alcohol outcomes: alcohol expectancies as a mediator.

Authors:  Cathy Lau-Barraco; Abby L Braitman; Kenneth E Leonard; Miguel Padilla
Journal:  Psychol Addict Behav       Date:  2012-06-25

3.  Drinking Buddies: Who Are They and When Do They Matter?

Authors:  Cathy Lau-Barraco; Ashley N Linden
Journal:  Addict Res Theory       Date:  2014

4.  Social network structure of a large online community for smoking cessation.

Authors:  Nathan K Cobb; Amanda L Graham; David B Abrams
Journal:  Am J Public Health       Date:  2010-05-13       Impact factor: 9.308

Review 5.  Smoking cessation in pregnancy.

Authors:  Renee Bittoun; Giuseppe Femia
Journal:  Obstet Med       Date:  2010-09-17

6.  Weekly versus basic smoking cessation support in primary care: a randomised controlled trial.

Authors:  Paul Aveyard; Karen Brown; Cas Saunders; Avril Alexander; Elaine Johnstone; Marcus R Munafò; Mike Murphy
Journal:  Thorax       Date:  2007-05-04       Impact factor: 9.139

Review 7.  The Past, Present, and Future of Nicotine Addiction Therapy.

Authors:  Judith J Prochaska; Neal L Benowitz
Journal:  Annu Rev Med       Date:  2015-08-26       Impact factor: 13.739

8.  The relation between social support and smoking cessation: revisiting an established measure to improve prediction.

Authors:  Rachel J Burns; Alexander J Rothman; Steven S Fu; Bruce Lindgren; Anne M Joseph
Journal:  Ann Behav Med       Date:  2014-06

9.  Commitment contracts and team incentives: a randomized controlled trial for smoking cessation in Thailand.

Authors:  Justin S White; William H Dow; Suthat Rungruanghiranya
Journal:  Am J Prev Med       Date:  2013-11       Impact factor: 5.043

10.  Share2Quit: Online Social Network Peer Marketing of Tobacco Cessation Systems.

Authors:  Rajani S Sadasivam; Sarah L Cutrona; Tana M Luger; Erik Volz; Rebecca Kinney; Sowmya R Rao; Jeroan J Allison; Thomas K Houston
Journal:  Nicotine Tob Res       Date:  2017-03-01       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.